Schrodinger SDGR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Software | $136.47M-11.0% | $148.5M+3.5% | $158.94M+16.0% | $152.6M+12.6% | $153.32M+18.0% | |
| Total revenues by Product | ||||||
| Hosted software | $46.33M+19.0% | $45.12M+28.0% | $44.76M+48.7% | $41.99M+57.0% | $38.95M+68.6% | |
| On-premise software | $90.21M-19.3% | $101.45M-2.5% | $112.49M+9.7% | $108.81M+4.5% | $111.82M+9.4% | |
| Professional services | $10.41M+16.2% | $9.65M-1.5% | $8.17M-22.1% | $8.62M-18.2% | $8.95M-10.7% | |
| Software maintenance | $27.16M+12.3% | $27.29M+17.2% | $26.29M+13.9% | $25.12M+8.4% | $24.18M+4.2% | |
| Software products and services | $186.24M-3.0% | $195.66M+8.5% | $206.04M+21.7% | $197.06M+18.4% | $191.92M+19.7% | |
| Total revenues by Geography | ||||||
| APAC | $72.25M-12.4% | $75.16M+12.9% | $97.87M+182% | $87.29M+162% | $82.44M+179% | |
| EMEA | $26.78M+5.1% | $26.18M+5.2% | $26.11M+7.6% | $24.64M+0.3% | $25.47M+10.8% | |
| Rest of World | $1.16M-13.5% | $1.56M+28.2% | $1.67M+44.2% | $1.4M+35.4% | $1.35M+25.9% | |
| United States | $154.71M+27.6% | $152.96M+33.2% | $131.3M-1.4% | $124.59M-12.0% | $121.24M-10.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Schrodinger break its business down?
- Schrodinger (SDGR) reports gross profit by business across 2 parts — Drug Discovery and Software. Each is extracted from the segment footnotes and tracked over time.
- Where does Schrodinger's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Schrodinger's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
